Corey Basch

Corey Basch is a highly experienced scientist specializing in medicinal chemistry, currently serving as Principal Scientist at Prelude Therapeutics since November 2019, after previously holding the position of Senior Research Scientist and Research Scientist. Prior to this role, Corey was a Postdoctoral Researcher at Columbia University in the City of New York from January 2018 to October 2019, focusing on organometallics, bioorganic chemistry, and metalloenzymes. Corey holds a Doctor of Philosophy (Ph.D.) in Chemistry from the University of Delaware, obtained in 2017, and a Bachelor of Science (B.S.) in Chemistry from Salisbury University, earned in 2011.